|
Volumn 15, Issue 2, 2004, Pages 91-92
|
Eprosartan dual action offers clinical benefit for elderly and overweight hypertensives.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACRYLIC ACID DERIVATIVE;
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
EPROSARTAN;
IMIDAZOLE DERIVATIVE;
THIOPHENE DERIVATIVE;
ADRENERGIC SYSTEM;
AGED;
ANIMAL;
AROUSAL;
ARTICLE;
BODY COMPOSITION;
CLINICAL TRIAL;
DRUG EFFECT;
FEMALE;
HUMAN;
HYPERTENSION;
MALE;
OBESITY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
ACRYLATES;
AGED;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
AROUSAL;
BODY COMPOSITION;
CLINICAL TRIALS;
FEMALE;
HUMANS;
HYPERTENSION;
IMIDAZOLES;
MALE;
OBESITY;
RECEPTOR, ANGIOTENSIN, TYPE 1;
RENIN-ANGIOTENSIN SYSTEM;
SYMPATHETIC NERVOUS SYSTEM;
THIOPHENES;
|
EID: 4644239566
PISSN: 10159657
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|